Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - Entia Biosciences, Inc.Financial_Report.xls
10-Q - ERGO 10-Q 09/30/12 - Entia Biosciences, Inc.ergo10q_093012apg.htm
XML - IDEA: XBRL DOCUMENT - Entia Biosciences, Inc.R3.htm
XML - IDEA: XBRL DOCUMENT - Entia Biosciences, Inc.R2.htm
XML - IDEA: XBRL DOCUMENT - Entia Biosciences, Inc.R8.htm
XML - IDEA: XBRL DOCUMENT - Entia Biosciences, Inc.R4.htm
XML - IDEA: XBRL DOCUMENT - Entia Biosciences, Inc.R1.htm
XML - IDEA: XBRL DOCUMENT - Entia Biosciences, Inc.R6.htm
XML - IDEA: XBRL DOCUMENT - Entia Biosciences, Inc.R7.htm
XML - IDEA: XBRL DOCUMENT - Entia Biosciences, Inc.R16.htm
XML - IDEA: XBRL DOCUMENT - Entia Biosciences, Inc.R22.htm
XML - IDEA: XBRL DOCUMENT - Entia Biosciences, Inc.R36.htm
XML - IDEA: XBRL DOCUMENT - Entia Biosciences, Inc.R42.htm
XML - IDEA: XBRL DOCUMENT - Entia Biosciences, Inc.R19.htm
XML - IDEA: XBRL DOCUMENT - Entia Biosciences, Inc.R43.htm
XML - IDEA: XBRL DOCUMENT - Entia Biosciences, Inc.R40.htm
XML - IDEA: XBRL DOCUMENT - Entia Biosciences, Inc.R34.htm
XML - IDEA: XBRL DOCUMENT - Entia Biosciences, Inc.R31.htm
XML - IDEA: XBRL DOCUMENT - Entia Biosciences, Inc.R29.htm
XML - IDEA: XBRL DOCUMENT - Entia Biosciences, Inc.R37.htm
XML - IDEA: XBRL DOCUMENT - Entia Biosciences, Inc.R35.htm
XML - IDEA: XBRL DOCUMENT - Entia Biosciences, Inc.R17.htm
XML - IDEA: XBRL DOCUMENT - Entia Biosciences, Inc.R15.htm
XML - IDEA: XBRL DOCUMENT - Entia Biosciences, Inc.R32.htm
XML - IDEA: XBRL DOCUMENT - Entia Biosciences, Inc.R11.htm
XML - IDEA: XBRL DOCUMENT - Entia Biosciences, Inc.R33.htm
XML - IDEA: XBRL DOCUMENT - Entia Biosciences, Inc.R13.htm
XML - IDEA: XBRL DOCUMENT - Entia Biosciences, Inc.R18.htm
XML - IDEA: XBRL DOCUMENT - Entia Biosciences, Inc.R39.htm
XML - IDEA: XBRL DOCUMENT - Entia Biosciences, Inc.R12.htm
XML - IDEA: XBRL DOCUMENT - Entia Biosciences, Inc.R24.htm
XML - IDEA: XBRL DOCUMENT - Entia Biosciences, Inc.R14.htm
XML - IDEA: XBRL DOCUMENT - Entia Biosciences, Inc.R28.htm
XML - IDEA: XBRL DOCUMENT - Entia Biosciences, Inc.R23.htm
EX-32.1 - EXHIBIT 32.1 - Entia Biosciences, Inc.ex32_1apg.htm
EX-31.1 - EXHIBIT 31.1 - Entia Biosciences, Inc.ex31_1apg.htm
EX-32.2 - EXHIBIT 32.2 - Entia Biosciences, Inc.ex32_2apg.htm
EX-31.2 - EXHIBIT 31.2 - Entia Biosciences, Inc.ex31_2apg.htm
XML - IDEA: XBRL DOCUMENT - Entia Biosciences, Inc.R5.htm
XML - IDEA: XBRL DOCUMENT - Entia Biosciences, Inc.R21.htm
XML - IDEA: XBRL DOCUMENT - Entia Biosciences, Inc.R26.htm
XML - IDEA: XBRL DOCUMENT - Entia Biosciences, Inc.R41.htm
XML - IDEA: XBRL DOCUMENT - Entia Biosciences, Inc.R20.htm
XML - IDEA: XBRL DOCUMENT - Entia Biosciences, Inc.R38.htm
XML - IDEA: XBRL DOCUMENT - Entia Biosciences, Inc.R10.htm
XML - IDEA: XBRL DOCUMENT - Entia Biosciences, Inc.R9.htm
XML - IDEA: XBRL DOCUMENT - Entia Biosciences, Inc.R30.htm
XML - IDEA: XBRL DOCUMENT - Entia Biosciences, Inc.R27.htm
v2.4.0.6
NOTE 7 - NOTES PAYABLE (Tables)
9 Months Ended
Sep. 30, 2012
Debt Disclosure [Abstract]  
Notes Payable
      September 30, 2012   December 31, 2011
Notes payable - current      
4.85%, unsecured, due monthly                           415                       20,664 
7.85% unsecured, due monthly                        2,812                          2,493 
         $                  3,227       $              23,157 
Convertible notes payable, net      
5% unsecured due June 2013 (net of discount related to beneficial conversion feature of $0 in 2012 and $5,143 in 2011), convertible into preferred stock at $5.00 per share    $               15,000       $                9,857 
5%, unsecured due June 2013  (net of discount related to beneficial conversion feature of $35,807 in 2012 and $127,701 in 2011), convertible into common stock at $0.45 per share                   276,693                     184,799 
6% unsecured due June 2013 (net of discount related to beneficial conversion feature of $6,416 in 2012 and $0 in 2011), convertible into preferred stock at $5.00 per share                        6,584     
5% unsecured due June 2013, convertible into preferred stock at $5.00  per share                      15,000                       15,000 
6% unsecured, convertible into common stock at $2.00 per share, due on demand                      50,000                       50,000 
Less:  Current Portion                  (363,277)                  (194,656)
         $                           -       $              65,000 
           
Convertible notes payable related party, net      
6% unsecured due December 2013 (net of discount related to beneficial conversion feature of $14,530 in 2012 and $0 in 2011), convertible into common stock at $2.00 per share    $               60,470       $              50,000